儿科中枢神经系统瘤:概述和治疗模式
Karishma Parikh1, Sameer Farouk Sait2
1Division of Child Neurology & Neurodevelopmental Disabilities, Department of Pediatrics, Rutgers-Robert Wood Johnson Medical Center, New Jersey, USA.
Seminars in pediatric neurology
|April 11, 2025
概括
儿科中枢神经系统 (CNS) 瘤,包括质瘤,脑髓母细胞瘤和脑膜瘤,越来越多地使用分子遗传学与组织病理学一起进行诊断. 这种整合有助于个性化治疗,并改善儿童大脑瘤的治疗结果.
科学领域:
- 儿科神经瘤学 儿科神经瘤学
- 分子诊断学 分子诊断
- 癌症遗传学 癌症遗传学
背景情况:
- 中枢神经系统 (CNS) 瘤是最常见的儿科固体瘤.
- 常见的类型包括质瘤,脑髓母细胞瘤和脑内膜瘤.
- 2021年世卫组织CNS5分类将分子数据与组织病理学整合在一起,以改善诊断和风险分层.
研究的目的:
- 审查当前儿科中枢神经系统瘤的情况.
- 突出分子诊断对诊断和治疗的影响.
- 讨论儿童中枢神经系统常见瘤的管理策略.
主要方法:
- 审查当前的文献和分类系统.
- 分析分子遗传学的诊断和预后影响.
- 小儿质瘤,脑膜瘤和脑髓母细胞瘤的治疗方法摘要.
主要成果:
- 分子遗传学整合完善了儿科中枢神经系统瘤的诊断和风险分层.
- 儿科低度结质瘤 (pLGG) 的存活率很好,但可能复发;治疗是为进展保留的.
- 儿科高度质瘤 (pHGG) 的存活率很低; 脑膜瘤和脑髓母细胞瘤根据类型和阶段的预后有所不同,多式疗法具有治愈潜力.
结论:
- 分子诊断的整合已经显著推进了儿科神经瘤学.
- 基于对瘤生物学有了更好的理解,个性化治疗模式正在出现.
- 对分子诊断的持续研究对于进一步改善儿童大脑瘤的结果至关重要.
关键词:
儿童中枢神经系统瘤更多相关视频
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...